Related references
Note: Only part of the references are listed.Long-term outcomes of moyamoya disease versus atherosclerosis-associated moyamoya vasculopathy using high-resolution MR vessel wall imaging
Mingming Lu et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)
The Genetic Basis of Moyamoya Disease
R. Mertens et al.
TRANSLATIONAL STROKE RESEARCH (2022)
Systemic vasculopathy associated with an RNF213 p.Arg4810Lys variant in moyamoya disease
Duk-Kyung Kim et al.
PRECISION AND FUTURE MEDICINE (2022)
Limits and pitfalls of indirect revascularization in moyamoya disease and syndrome
Pietro Fiaschi et al.
NEUROSURGICAL REVIEW (2021)
Moyamoya Disease Associated with Graves' Disease and Down Syndrome: A Case Report and Literature Review
Hikaru Nakamura et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2021)
Genotype-Phenotype Correlations in Neurofibromatosis Type 1: A Single-Center Cohort Study
Marcello Scala et al.
CANCERS (2021)
RNF213 and GUCY1A3 in Moyamoya Disease: Key Regulators of Metabolism, Inflammation, and Vascular Stability
Yohei Mineharu et al.
FRONTIERS IN NEUROLOGY (2021)
Differences in Clinical Features among Different Onset Patterns in Moyamoya Disease
Yudai Hirano et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Outcomes in Patients with Moyamoya Syndrome and Sickle Cell Disease: A Systematic Review
Sarah Newman et al.
WORLD NEUROSURGERY (2020)
Radiation-Induced Moyamoya Syndrome in Children with Brain Tumors: Case Series and Literature Review
Marcello Scala et al.
WORLD NEUROSURGERY (2020)
Spatial coefficient of variation applied to arterial spin labeling MRI may contribute to predict surgical revascularization outcomes in pediatric moyamoya vasculopathy
Domenico Tortora et al.
NEURORADIOLOGY (2020)
Biomechanical signal communication in vascular smooth muscle cells
Jingbo Chen et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2020)
Moyamoya-like cerebrovascular disease in a child with a novel mutation in myosin heavy chain 11
Annette Keylock et al.
NEUROLOGY (2018)
Vascular smooth muscle cell proliferation as a therapeutic target. Part 1: molecular targets and pathways
Dongdong Wang et al.
BIOTECHNOLOGY ADVANCES (2018)
When and why is surgical revascularization indicated for the treatment of moyamoya syndrome in patients with RASopathies? A systematic review of the literature and a single institute experience
Marcello Scala et al.
CHILDS NERVOUS SYSTEM (2018)
Whole exome sequencing identifies MRVI1 as a susceptibility gene for moyamoya syndrome in neurofibromatosis type 1
Claudia Santoro et al.
PLOS ONE (2018)
Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians
Stephanie Guey et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2017)
Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review
Xin Liao et al.
ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE (2017)
Moyamoya syndrome in children with neurofibromatosis type 1: Italian-French experience
Claudia G Santoro et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2017)
A new horizon of moyamoya disease and associated health risks explored through RNF213
Akio Koizumi et al.
ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE (2016)
Endothelial RSPO3 Controls Vascular Stability and Pruning through Non-canonical WNT/Ca2+/NFAT Signaling
Beate Scholz et al.
DEVELOPMENTAL CELL (2016)
Neurofibromin is a novel regulator of Ras-induced reactive oxygen species production in mice and humans
Waylan K. Bessler et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Association between moyamoya syndrome and the RNF213 c.14576G>A variant in patients with neurofibromatosis Type 1
Ji Hoon Phi et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2016)
Clinical characteristics and long-term outcomes of moyamoya syndrome associated with neurofibromatosis type 1
Cong Han et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2015)
Neurofibromatosis Type 1 Associated With Moyamoya Syndrome in Children
Anna Duat-Rodriguez et al.
PEDIATRIC NEUROLOGY (2014)
Cerebral Vasculopathy in Children With Neurofibromatosis Type 1
Partha S. Ghosh et al.
JOURNAL OF CHILD NEUROLOGY (2013)
Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease
S. Miyatake et al.
NEUROLOGY (2012)
Loss of NF1 Expression in Human Endothelial Cells Promotes Autonomous Proliferation and Altered Vascular Morphogenesis
Anshika Bajaj et al.
PLOS ONE (2012)
A genome-wide association study identifies RNF213 as the first Moyamoya disease gene
Fumiaki Kamada et al.
JOURNAL OF HUMAN GENETICS (2011)
Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development
Wanyang Liu et al.
PLOS ONE (2011)
Mutations in Smooth Muscle Alpha-Actin (ACTA2) Cause Coronary Artery Disease, Stroke, and Moyamoya Disease, Along with Thoracic Aortic Disease
Dong-Chuan Guo et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2009)
MEDICAL PROGRESS Moyamoya Disease and Moyamoya Syndrome
R. Michael Scott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cerebral Arteriopathy in Children With Neurofibromatosis Type 1
David Rea et al.
PEDIATRICS (2009)
Cerebrovascular dysplasia in neurofibromatosis type 1
A. G. Cairns et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Moyamoya disease: current concepts and future perspectives
Satoshi Kuroda et al.
LANCET NEUROLOGY (2008)
NF1 regulates a ras-dependent vascular smooth muscle proliferative injury response
Junwang Xu et al.
CIRCULATION (2007)
Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells
Fang Li et al.
HUMAN MOLECULAR GENETICS (2006)
Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells
Amy M. Munchhof et al.
HUMAN MOLECULAR GENETICS (2006)
Share Paper
